Khezrian, MinaWaymont, Jennifer M.J.Myint, Phyo KMcNeil, Christopher JWhalley, LawrenceStaff, RogerMurray, Alison D2021-01-072021-01-072020-03-01Khezrian, M, Waymont, J M J, Myint, P K, McNeil, C J, Whalley, L, Staff, R & Murray, A D 2020, 'Aspirin moderates the association between cardiovascular risk, brain white matter hyperintensity total lesion volume and processing speed in normal ageing', Maturitas, vol. 133, pp. 49-53. https://doi.org/10.1016/j.maturitas.2020.01.0010378-5122ORCID: /0000-0003-4915-4847/work/76976605unpaywall: 10.1016/j.maturitas.2020.01.001ORCID: /0000-0003-3852-6158/work/163198719ORCID: /0000-0001-6688-7132/work/199810515https://hdl.handle.net/2164/15596ABC1936 was funded (1999-2009) by the Biotechnology and Biological Sciences Research Council, Scottish Health Department, Wellcome Trust, Medical Research Council, Alzheimer Research UK, Alzheimer Society and University of Aberdeen Development Trust. This work was supported by the Elphinstone Scholarship, Roland Sutton Academic Trust, the Morningfield Association and the Rabin Ezra Scholarship Trust, which provides salary cost and consumables to MK.5301263engaspirincardiovascular riskbrain white matter hyperintensitycognitionolder adultsAspirinBrain white matter hyperintensityCardiovascular riskCognitionOlder adultsSMALL VESSEL DISEASEDEMENTIAPREVENTIONCOLLABORATIVE METAANALYSISCOGNITIVE FUNCTIONDECLINEHYPERTENSIONWOMENS HEALTHREDUCER Medicine (General)General Biochemistry,Genetics and Molecular BiologyObstetrics and GynaecologyMedical Research Council (MRC)Alzheimers Research UKBiotechnology and Biological Sciences Research Council (BBSRC)Wellcome TrustSupplementary DatafileR1Journal article10.1016/j.maturitas.2020.01.001https://www.scopus.com/pages/publications/85077652926